This treatment, an enzyme called collagenase, and sold under the trade name Xiaflex, is injected into the hands where Dupuytren's has formed. ❋ Unknown (2010)
Nature accomplished this purpose superbly which is why no other enzyme (of the many thousands in the body) but a "collagenase" or collagen can break it into its component parts. ❋ Unknown (2010)
The proteolytic enzymes and proteases such as collagenase and cathepsins are necessary for this purpose, and thus play crucial roles in multiple steps of cancer growth and metastasis ❋ Unknown (2009)
The temperature of local joints affects levels of destructive enzymes such as collagenase, elastase, hyaluronidase, and protease. ❋ Abdulrehmanm (2009)
Bullard KM, Cass DL, Banda MJ, Adzick NS: TGF-beta1 decreases collagenase in healing human fetal skin. ❋ Unknown (2010)
She stated that Retin A was able to "boost collagen production and reduce production of collagenase, an enzyme that breaks down collagen." ❋ Unknown (2010)
Matrix metalloproteinases (MMPs) are enzymes (one of which is collagenase) that break down and eliminate old or damaged proteins such as collagen and GAGs. ❋ Ellen Marmur (2009)
Dagum says cellulite can be reduced by injecting infected areas with collagenase, an enzyme that digests collagen. ❋ Unknown (2007)
After months of trying several means of disrupting adipose tissue, I discovered that collagenase (actually an impure preparation containing many proteases) rapidly digested the tissue matrix, releasing the fat cells. ❋ Unknown (1995)
Auxilium markets XIAFLEX® (collagenase clostridium histolyticum) for the treatment of adult Dupuytren's contracture patients with a palpable cord and Testim® 1%, a testosterone gel, for the topical treatment of hypogonadism in the U.S. Pfizer Inc. has marketing rights for XIAPEX® (the EU tradename for collagenase clostridium histolyticum) in 46 countries in Eurasia and Asahi Kasei Pharma Corporation has development and commercial rights for XIAFLEX in
(NASDAQ: AUXL - News), a specialty biopharmaceutical company, today announced three year recurrence data from the Collagenase Optimal Reduction of Dupuytren's - Long-term Evaluation of Success Study (CORDLESS) for XIAFLEX ® (collagenase clostridium histolyticum) in the treatment of adult Dupuytren's contracture patients with a palpable cord.
Auxilium markets XIAFLEX® (collagenase clostridium histolyticum) for the treatment of adult Dupuytren's contracture patients with a palpable cord and Testim® 1%, a testosterone gel, for the topical treatment of hypogonadism in the U.S. Pfizer Inc. has marketing rights for XIAPEX® (the EU trade name for collagenase clostridium histolyticum)in 46 countries in Eurasia and Asahi Kasei Pharma Corporation has development and commercial rights for XIAFLEX in
Auxilium markets XIAFLEX® (collagenase clostridium histolyticum) for the treatment of adult Dupuytren's contracture patients with a palpable cord and Testim® 1%, a testosterone gel, for the topical treatment of hypogonadism in the U.S. Pfizer has marketing rights for XIAPEX® (the EU tradename for collagenase clostridium histolyticum) in
